Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1959 1
1961 1
1963 1
1964 3
1965 1
1968 3
1969 2
1970 6
1971 4
1972 2
1974 1
1976 1
1978 1
1979 1
1980 1
1983 1
1984 1
1987 1
1989 1
1994 1
1997 1
2000 1
2001 1
2006 2
2009 1
2012 3
2013 1
2014 4
2015 5
2016 6
2017 3
2018 8
2019 5
2020 19
2021 15
2022 10
2023 6
2024 8
2025 10
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort Study.
Tursi A, Pasta A, Elisei W, Barberio B, Mocci G, Savarino EV, de Barba C, Maconi G, Cataletti G, Scaldaferri F, Napolitano D, Costa F, Ceccarelli L, Marzo M, Monterubbianesi R, di Fonzo M, Lombardi G, Patturelli M, Ribaldone DG, Bertani L, Rodino' S, Sebkova L, Bodini G, Pranzo G, Serio M, Scarcelli A, Luppino I, Ferronato A, Spagnuolo R, Luzza F, Morano D, Gravina AG, Pellegrino R, Vespere G, Sedda S, Allegretta L, Fanigliulo L, Grossi L, Cortellini F, Forti G, Neve V, Piergallini S, Scarozza P, Bevevino G, Iacopini F, Capone P, Gaiani F, Kayali S, Mucherino C, D'antonio E, D'ascoli B, Colucci R, Bachetti F, Giorgetti GM, Clemente V, Pagnini C, Cuomo A, Donnarumma L, Onidi FM, Satta PU, Picchio M, Papa A; Italian Network for Inflammatory Bowel Diseases (IN-IBD). Tursi A, et al. Among authors: bertani l. Adv Ther. 2026 May 9. doi: 10.1007/s12325-026-03622-3. Online ahead of print. Adv Ther. 2026. PMID: 42105145
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study.
Scaldaferri F, Di Vincenzo F, Aloi M, Ascolani M, Balestrieri P, Bertani L, Bezzio C, Bodini G, Bossa F, Calabrese E, Cannatelli R, Caprioli F, Cappello M, Cicala M, D'Amico F, Danese S, De Bernardi A, De Filippo FR, Desideri F, Di Paolo D, Di Sario A, Fantini MC, Ferracane C, Festa S, Fiorino G, Gabbiadini R, Geccherle A, Gerardi V, Giangreco E, Gravina AG, Laterza L, Lopetuso LR, Marafini I, Mastronardi M, Mendolaro M, Merli M, Mocci G, Onali S, Onidi MF, Pastorelli L, Piagnani A, Principi MB, Pugliese D, Ribaldone DG, Rispo A, Rizzello F, Santagata F, Savarino EV, Spagnuolo R, Tursi A, Panarese A, Mazzuoli S, Variola A, Viganò C, Armuzzi A; RESOLVE Study Group. Scaldaferri F, et al. Among authors: bertani l. Am J Gastroenterol. 2026 Feb 18. doi: 10.14309/ajg.0000000000003969. Online ahead of print. Am J Gastroenterol. 2026. PMID: 41705712 Free article.
The right drug at the right time: key to IBD success.
Ribaldone DG, Valdiserra G, Di Salvo C, Puxeddu I, Bertani L, Antonioli L. Ribaldone DG, et al. Among authors: bertani l. Trends Mol Med. 2025 Nov 27:S1471-4914(25)00264-3. doi: 10.1016/j.molmed.2025.10.010. Online ahead of print. Trends Mol Med. 2025. PMID: 41314864 Review.
Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study.
Mocci G, Tursi A, Scaldaferri F, Napolitano D, Pugliese D, Maconi G, Cataletti G, Pica R, Cassieri C, Savarino EV, De Barba C, Costa F, Ceccarelli L, Marzo M, Elisei W, Monterubbianesi R, Faggiani R, Lombardi G, Patturelli M, Ribaldone DG, Bertani L, Rodinò S, Sebkova L, Bodini G, Pasta A, Pranzo G, Serio M, Scarcelli A, Luppino I, Ferronato A, Spagnuolo R, Luzza F, Gravina AG, Pellegrino R, Vespere G, Sedda S, D'Onofrio V, De Luca L, Allegretta L, Cazzato AI, Fanigliuolo L, Grossi L, Cortellini F, Forti G, Tonti P, Neve V, Piergallini S, Di Fonzo M, Iacopini F, Capone P, Gaiani F, Kayali S, Mucherino C, D'Antonio E, Montesano L, Cocco A, D'Ascoli B, Colucci R, Bachetti F, Orrù G, Onidi FM, Usai Satta P, Picchio M, Papa A. Mocci G, et al. Among authors: bertani l. J Clin Med. 2025 Nov 3;14(21):7801. doi: 10.3390/jcm14217801. J Clin Med. 2025. PMID: 41227197 Free PMC article.
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.
Innocenti T, Hanžel J, Truyens M, Lukaš M, Gordon H, Cremer A, Molnár T, Julsgaard M, Onali S, Todeschini A, Nardone OM, Noor NM, Caprioli F, Scaldaferri F, Argyriou K, Savarino EV, Brinar M, Hedin CRH, Vela González M, Armuzzi A, Blesl A, Aratari A, Quadarella A, Parigi TL, Bertani L, Ferracane C, Uzzan M, Michalopoulos G, De Bernardi A, Katsanos K, Balestrieri P, Piñero G, Karmiris K, Casbas AG, Nikolic S, Felice C, Pugliese D, Pastras P, Mocci G, Pouillon L, Mantzaris GJ, Ramos L, Casanova MJ, Koutroubakis IE, García MJ, Lobaton T, Dragoni G, Study Group TJ. Innocenti T, et al. Among authors: bertani l. J Crohns Colitis. 2026 Feb 5;20(2):jjaf188. doi: 10.1093/ecco-jcc/jjaf188. J Crohns Colitis. 2026. PMID: 41183095
141 results